Aikium is a startup based in the United States, 1 tracked investor.
Based in the United States, Aikium is a startup. Brouky records 1 investor associated with the company.
Aikium develops an AI-driven platform combining deep learning and large-scale wet lab experimentation to design and screen protein therapeutics that target challenging disease-associated proteins missed by traditional drug discovery methods.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.